This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: University of California. Active years: 2016-2021.
Company Filing History:
Years Active: 2016-2021
Title: Manuel Ruidiaz: Innovator in Antibody Detection Methods
Introduction
Manuel Ruidiaz is a prominent inventor based in La Jolla, California. He has made significant contributions to the field of antibody detection, holding a total of 3 patents. His work focuses on developing innovative methods that enhance the detection of therapeutic monoclonal antibodies.
Latest Patents
One of Manuel Ruidiaz's latest patents involves methods for detecting antibodies through complexes comprising a therapeutic monoclonal antibody and a peptide. In this invention, the complexes may include a therapeutic monoclonal antibody that is not complexed to an epitope of a target protein, along with a peptide that is complexed to the therapeutic monoclonal antibody. The peptide may range in length from about 5 to 40 amino acids and can include a mimetope recognized by the therapeutic monoclonal antibody. Notably, the mimetope features a linear sequence of amino acids that differs from the linear sequence of amino acids found in the epitope of the target protein.
Career Highlights
Manuel Ruidiaz is affiliated with the University of California, where he continues to advance research in his field. His innovative approaches have garnered attention and recognition within the scientific community.
Collaborations
He has collaborated with notable colleagues, including Thomas James Kipps and Bradley T Messmer, further enhancing the impact of his research.
Conclusion
Manuel Ruidiaz's contributions to antibody detection methods exemplify the importance of innovation in the medical field. His work not only advances scientific understanding but also holds potential for significant therapeutic applications.